Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician
NPJ Metab Health Dis Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression
While oral formulations are beginning to enter the market, so far they remain less effective and more expensive to manufacture
This could lead to elevated blood sugar levels, a situation anyone with type 2 diabetes would want to avoid
Product Web Link About the Company : Sinopep leads the industry in therapeutic peptides, supplying top-demand APIs like Albuvirtide, Lanreotide, Semaglutide, and more
Aging 5 , 19461956 (2025)
